Th17 cells could facilitate wider clinical use of adoptive immunotherapy – Medical Xpress
Medical Xpress |
Th17 cells could facilitate wider clinical use of adoptive immunotherapy
Medical Xpress Medical University of South Carolina (MUSC) investigators report that long-term expansion protocols for adoptive cancer immunotherapy do not compromise Th17 cells' effectiveness against large tumors, in the March 9, 2017 issue of JCI Insight. This … |
